Expression of vitamin D3 receptor in kidney tumors
- PMID: 16949927
- DOI: 10.1016/j.humpath.2006.04.029
Expression of vitamin D3 receptor in kidney tumors
Abstract
The kidney is not only a primary vitamin D target organ but also is a key site of vitamin D metabolism. Recent studies have shown that vitamin D has important physiologic effects on proliferation and differentiation in a variety of benign and malignant cells. Our preliminary immunohistochemical study showed that vitamin D receptor (VDR) was highly expressed in renal distal tubules and collecting ducts, whereas the renal proximal tubules and glomeruli did not express VDR. These observations led us to study the expression of VDR in various kidney tumors to determine the possible diagnostic utility of VDR. Paraffin tissue microarray (TMA) blocks were constructed containing core cylinders from clear cell (52), papillary (35), chromophobe (20), sarcomatoid (20), and metastatic (59) renal cell carcinomas (RCCs). Oncocytomas (20), normal adult kidneys (12), and normal adult adrenals (6) were also included. In addition, 30 clear cell RCCs and 3 collecting duct carcinomas were also studied using conventional sections. Furthermore, VDR messenger RNA and protein expression was also quantified using real-time reverse transcriptase-polymerase chain reaction and Western blot analysis. Vitamin D receptor was strongly positive in collecting duct carcinomas (100% [3/3], cytoplasmic), papillary RCCs (94% [33/35], cytoplasmic), chromophobe RCCs (85% [17/20], membranous), and oncocytomas (90% [18/20], cytoplasmic with perinuclear accentuation). In contrast, VDR expression was focal/weak and present only in the peripheral regions of clear cell RCCs. Vitamin D receptor was weakly positive in sarcomatoid variant RCCs (88% [14/16]) regardless of the type of associated original RCC. Overall, VDR is a discriminative marker for renal cell tumors. The preferential expression of VDR in chromophobe RCCs, oncocytomas, and collecting duct carcinomas is in agreement with the concept that these tumors differentiate toward epithelium lining the distal convoluted tubules and collecting ducts. Considering the different VDR expression patterns, VDR is a useful ancillary tool in distinguishing chromophobe RCCs from oncocytomas. In addition, the focal and much weaker VDR expression in clear cell RCCs makes VDR valuable in distinguishing clear cell RCC from other types of RCCs.
Similar articles
-
Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.Am J Surg Pathol. 2007 Oct;31(10):1528-33. doi: 10.1097/PAS.0b013e318058818c. Am J Surg Pathol. 2007. PMID: 17895753
-
C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.Hum Pathol. 2005 Mar;36(3):262-8. doi: 10.1016/j.humpath.2005.01.011. Hum Pathol. 2005. PMID: 15791570
-
Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.Hum Pathol. 2001 Oct;32(10):1071-7. doi: 10.1053/hupa.2001.28235. Hum Pathol. 2001. PMID: 11679941
-
[Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology].Ann Pathol. 2008 Oct;28(5):381-401. doi: 10.1016/j.annpat.2008.07.009. Epub 2008 Oct 17. Ann Pathol. 2008. PMID: 19068393 Review. French.
-
Renal tumors exhibiting granular cytoplasm.Semin Diagn Pathol. 1999 May;16(2):135-45. Semin Diagn Pathol. 1999. PMID: 10452579 Review.
Cited by
-
Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.PLoS One. 2018 Apr 16;13(4):e0195844. doi: 10.1371/journal.pone.0195844. eCollection 2018. PLoS One. 2018. PMID: 29659618 Free PMC article.
-
Identification of the vitamin D receptor in various cells of the mouse kidney.Kidney Int. 2012 May;81(10):993-1001. doi: 10.1038/ki.2011.463. Epub 2012 Jan 25. Kidney Int. 2012. PMID: 22278022 Free PMC article.
-
Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.J Histochem Cytochem. 2012 Jul;60(7):502-11. doi: 10.1369/0022155412447296. Epub 2012 Apr 17. J Histochem Cytochem. 2012. PMID: 22511602 Free PMC article.
-
MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma.Int J Med Sci. 2021 Jan 1;18(1):150-156. doi: 10.7150/ijms.49328. eCollection 2021. Int J Med Sci. 2021. PMID: 33390783 Free PMC article.
-
Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.J Clin Oncol. 2011 Jun 10;29(17):2378-85. doi: 10.1200/JCO.2010.30.9880. Epub 2011 May 2. J Clin Oncol. 2011. PMID: 21537045 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical